1. Barclay, L. (2004), “Vioxx withdrawal prompts reevaluation of COX‐2 inhibitor safety”, New England Journal of Medicine, available at: www.medscape.com/viewarticle/490979 (accessed 17 March 2008).
2. Barnett, A. (1998), “Are drug ads a cure‐all?”, Business Week, March 30, pp. 59‐60.
3. Spinal interleukin-1β in a mouse model of arthritis and joint pain
4. Gardner, D.M., Mintzes, B. and Ostry, A. (2003), “Direct‐to‐consumer prescription drug advertising in Canada: permission by default?”, Canadian Medical Association Journal, Vol. 169 No. 5, pp. 1‐6.
5. Gregory, S. (2009), “Are direct‐to‐consumer drug ads doomed?”, Time, 4 February, available at: www.time.com/time/business/article/0,8599,1876679‐1,00.html (accessed 11 March 2009).